All News #Library
Biotech
Heron Adopts Plan to Protect NOL Assets, Shareholder Value
15 Aug 2025 //
PR NEWSWIRE
Heron Therapeutics Restructures Capital for Growth
08 Aug 2025 //
PR NEWSWIRE
Heron Therapeutics Reports Q2 2025 Financial Results, Progress
08 Aug 2025 //
PR NEWSWIRE
Heron Therapeutics to Report Q4 & Full Year 2024 Financial Results
13 Feb 2025 //
PR NEWSWIRE
Heron Therapeutics Announces Q3 2024 Financial Results & Guidance
12 Nov 2024 //
PR NEWSWIRE
Heron Announces FDA Approval for Zynrelef
25 Sep 2024 //
PR NEWSWIRE

Market Place
Sourcing Support